[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578314":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":23,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":10,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":10,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":75},{"fullName":5,"class":6},"Richmond Pharmacology Limited","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction",null,"Study to Collect High Resolution 12-Lead Electrocardiogram (ECG) Data for the Development of an ECG Library to Support the Development of a Tool to Monitor Disease Progression, Gather Patient Perspectives on Standard of Care Heart Failure Procedures and Facilitate Familiarity with the Clinical Trial Environment in Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction",[13],{"name":14,"affiliation":15,"role":16},"Principal Investigator","Richmond Pharmacology","PRINCIPAL_INVESTIGATOR",[18],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"Volunteer Recruitment Team","CONTACT","+44 (0) 207 042 5800","volunteer@richmondpharmacology.com",[24,39],{"facility":15,"status":25,"city":26,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"RECRUITING","London","SE1 1YR","United Kingdom","UK",{"type":31,"coordinates":32},"Point",[33,34],-0.12574,51.50853,{"lat":34,"lon":33},[37],{"name":19,"role":20,"phone":38,"phoneExt":10,"email":22},"+44 (0) 20 7042 5800",{"facility":15,"status":25,"city":26,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":40,"geoPoint":42,"contacts":43},{"type":31,"coordinates":41},[33,34],{"lat":34,"lon":33},[44],{"name":45,"role":20,"phone":10,"phoneExt":10,"email":10},"Volunteer Recruitment",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100578314","study-to-collect-high-resolution-ecg-data-and-patient-insights-on-heart-failure-care-100578314",false,"NCT06809686","Study to Collect High-Resolution ECG Data and Patient Insights on Heart Failure Care","An Observational Study to Collect High Resolution 12-Lead Electrocardiogram (ECG) Data for the Development of an ECG Library to Support the Development of a Tool to Monitor Disease Progression, Gather Patient Perspectives on Standard of Care Heart Failure Procedures and Facilitate Familiarity With the Clinical Trial Environment in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction","Inclusion Criteria:\n\n1. Male or female participants aged 45 to 80 years (inclusive) at the date of signing the informed consent.\n2. Diagnosed with heart failure.\n3. Able and willing to provide informed consent to participate.\n\nExclusion Criteria:\n\n1. Diagnostic test results positive for:\n\n   1. HIV-1 or HIV-2 infection\n   2. Hepatitis B or Hepatitis C infection\n2. Mental incapacity, language barriers or unwillingness to comply with the requirements of the protocol, which may preclude adequate understanding or cooperation during the study as judged by the Investigator.\n3. Any condition judged by the Investigator to pose an undue risk while participating in the trial\n4. Diagnostic results which are inconsistent with heart failure with mildly reduced or preserved ejection fraction as judged by the Investigator.","ALL","45 Years","80 Years",{"count":59,"type":60},1000,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to establish an electrocardiogram (ECG) data library to facilitate future studies on heart disease. Additionally, the study will be used to monitor changes in the patient's standard of care throughout the study period and gather patient perspectives on routine diagnostic procedures and disease monitoring and feedback on the design of heart failure trials.",[64],"Heart Failure","2026-05-18",{"date":67,"type":68},"2026-05-20","ACTUAL",{"date":70,"type":68},"2025-02-05",{"date":72,"type":60},"2027-02-21",{"name":74,"class":6},"Richmond Research Institute",2]